<DOC>
	<DOCNO>NCT02190994</DOCNO>
	<brief_summary>The purpose four-arm randomize control study determine whether eliminate glucocorticoid ( GC ) replacement perioperative period surgical patient sellar lesion could result similar good outcome compare traditional replacement therapy , regard postoperative recovery pituitary function postoperative complication ( infection , pain , quality life , recurrence ) . Surgical patient center MRI-confirmed diagnosis sellar lesion enrol , insulin tolerance test ( ITT ) perform assessment pituitary function enrollment . Patients normal pituitary function randomize non-GC replacement group ( group A ) low-dose GC replacement group ( group B ) , patient impair pituitary function randomize low-dose GC replacement group ( group C ) high-dose GC replacement group ( group D ) . The primary outcome hypothalamic-pituitary-adrenal ( HPA ) -axis function patient , evaluate plasma cortisol adrenocorticotropic hormone ( ACTH ) level . The secondary outcome include hypothalamic-pituitary-thyroid ( HPT ) axis function ( TSH , thyroid-stimulating hormone , free T3 , free T4 ) , postoperative water-electrolyte balance , infection , recurrence health-related quality life .</brief_summary>
	<brief_title>Effect Perioperative Glucocorticoid Replacement Prognosis Surgical Patients With Sellar Lesions</brief_title>
	<detailed_description />
	<mesh_term>Pituitary Diseases</mesh_term>
	<mesh_term>Craniopharyngioma</mesh_term>
	<mesh_term>Adamantinoma</mesh_term>
	<mesh_term>Pituitary Neoplasms</mesh_term>
	<mesh_term>Hydrocortisone 17-butyrate 21-propionate</mesh_term>
	<mesh_term>Cortisol succinate</mesh_term>
	<mesh_term>Hydrocortisone acetate</mesh_term>
	<mesh_term>Prednisone</mesh_term>
	<mesh_term>Hydrocortisone</mesh_term>
	<mesh_term>Glucocorticoids</mesh_term>
	<criteria>Age &gt; = 18 Surgical patient MRIconfirmed diagnosis sellar lesion ( nonfunctioning pituitary adenoma craniopharyngioma ) Patients preexist hyperthyroidism Cushing 's syndrome Patients longterm glucocorticoids replacement history Patients comorbidities pose know influence upon HPAaxis function ( cardiovascular cerebrovascular disease , metabolic disease epilepsy ) Patients severe panhypopituitarism Patients history radiotherapy pituitary gland</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Hydrocortisone</keyword>
	<keyword>Pituitary adenoma</keyword>
	<keyword>Replacement therapy</keyword>
</DOC>